Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Aptus Pharma Ltd (NSE: APPL), ISIN INE15XJ01010 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
APPL last traded at ₹464.00 (+0.42%), with a 52-week range of ₹57.20 to ₹510.90 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 72.89%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 60/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.